147 related articles for article (PubMed ID: 31592776)
1. No hyperfibrinolysis following subarachnoid or intracerebral haemorrhage: a prospective cohort study.
Lauridsen SV; Hvas CL; Sandgaard E; Gyldenholm T; Tønnesen EK; Hvas AM
Blood Coagul Fibrinolysis; 2019 Oct; 30(7):341-349. PubMed ID: 31592776
[TBL] [Abstract][Full Text] [Related]
2. Fibrinolysis in trauma patients: wide variability demonstrated by the Lysis Timer.
Roullet S; Weinmann L; Labrouche S; Gisbert-Mora C; Biais M; Revel P; Freyburger G
Scand J Clin Lab Invest; 2019; 79(1-2):136-142. PubMed ID: 30861350
[TBL] [Abstract][Full Text] [Related]
3. Does Tranexamic Acid Improve Clot Strength in Severely Injured Patients Who Have Elevated Fibrin Degradation Products and Low Fibrinolytic Activity, Measured by Thrombelastography?
Moore HB; Moore EE; Chapman MP; Hansen KC; Cohen MJ; Pieracci FM; Chandler J; Sauaia A
J Am Coll Surg; 2019 Jul; 229(1):92-101. PubMed ID: 30936005
[TBL] [Abstract][Full Text] [Related]
4. Temporal changes in clot lysis and clot stability following tranexamic acid in cardiac surgery.
Tang M; Wierup P; Rea CJ; Ingerslev J; Hjortdal VE; Sørensen B
Blood Coagul Fibrinolysis; 2017 Jun; 28(4):295-302. PubMed ID: 27607599
[TBL] [Abstract][Full Text] [Related]
5. Factor XIII and tranexamic acid but not recombinant factor VIIa attenuate tissue plasminogen activator-induced hyperfibrinolysis in human whole blood.
Dirkmann D; Görlinger K; Gisbertz C; Dusse F; Peters J
Anesth Analg; 2012 Jun; 114(6):1182-8. PubMed ID: 22104068
[TBL] [Abstract][Full Text] [Related]
6. Stabilization of fibrin clots by activated prothrombin complex concentrate and tranexamic acid in FVIII inhibitor plasma.
Dai L; Bevan D; Rangarajan S; Sørensen B; Mitchell M
Haemophilia; 2011 Sep; 17(5):e944-8. PubMed ID: 21371192
[TBL] [Abstract][Full Text] [Related]
7. Ex vivo effect of hemostatic therapy in subarachnoid and intracerebral hemorrhage.
Hvas CL; Lauridsen SV; Pedersen ES; Gyldenholm T; Hvas AM
Thromb Res; 2020 May; 189():42-47. PubMed ID: 32163792
[TBL] [Abstract][Full Text] [Related]
8. Changes in the Lectin Pathway Following Intracerebral or Spontaneous Subarachnoid Hemorrhage.
Sandgaard E; Troldborg A; Lauridsen SV; Gyldenholm T; Thiel S; Hvas AM
Mol Neurobiol; 2019 Jan; 56(1):78-87. PubMed ID: 29675579
[TBL] [Abstract][Full Text] [Related]
9. Reduced clot-stability during the first 6 hours after aneurysmal subarachnoid haemorrhage--a prospective case-control study.
Larsen CC; Sørensen B; Nielsen JD; Astrup J
Thromb Res; 2012 May; 129(5):e229-32. PubMed ID: 22386137
[TBL] [Abstract][Full Text] [Related]
10. Effect of Tranexamic Acid on Coagulation and Fibrin Clot Properties in Children Undergoing Craniofacial Surgery.
Fenger-Eriksen C; Lindholm AD; Krogh L; Hell T; Berger M; Hermann M; Fries D; Juul N; Rasmussen M; Hvas AM
Thromb Haemost; 2020 Mar; 120(3):392-399. PubMed ID: 32016928
[TBL] [Abstract][Full Text] [Related]
11. Effective tranexamic acid concentration for 95% inhibition of tissue-type plasminogen activator induced hyperfibrinolysis in children with congenital heart disease: A prospective, controlled, in-vitro study.
Rozen L; Faraoni D; Sanchez Torres C; Willems A; Noubouossie DC; Barglazan D; Van der Linden P; Demulder A
Eur J Anaesthesiol; 2015 Dec; 32(12):844-50. PubMed ID: 26258658
[TBL] [Abstract][Full Text] [Related]
12. Thromboelastometry Shows Early Hypercoagulation in Patients with Spontaneous Subarachnoid Hemorrhage.
Lauridsen SV; Hvas CL; Sandgaard E; Gyldenholm T; Mikkelsen R; Obbekjær T; Sunde N; Tønnesen EK; Hvas AM
World Neurosurg; 2019 Oct; 130():e140-e149. PubMed ID: 31327692
[TBL] [Abstract][Full Text] [Related]
13. Experimental model of hyperfibrinolysis designed for rotational thromboelastometry in children with congenital heart disease.
Faraoni D; Rozen L; Willems A; Torres CS; Pereira LM; Demulder A; Van der Linden P
Blood Coagul Fibrinolysis; 2015 Apr; 26(3):290-7. PubMed ID: 25806960
[TBL] [Abstract][Full Text] [Related]
14. Effective tranexamic acid concentration for 95% inhibition of tissue-type plasminogen activator-induced hyperfibrinolysis in full-term pregnant women: a prospective interventional study.
Lechien A; Faraoni D; Van der Linden P
Blood Coagul Fibrinolysis; 2021 Apr; 32(3):186-193. PubMed ID: 33470644
[TBL] [Abstract][Full Text] [Related]
15. An in vitro study of the effects of t-PA and tranexamic acid on whole blood coagulation and fibrinolysis.
Godier A; Parmar K; Manandhar K; Hunt BJ
J Clin Pathol; 2017 Feb; 70(2):154-161. PubMed ID: 27445340
[TBL] [Abstract][Full Text] [Related]
16. Synergism of red blood cells and tranexamic acid in the inhibition of fibrinolysis.
Raska A; Kálmán K; Egri B; Csikós P; Beinrohr L; Szabó L; Tenekedjiev K; Nikolova N; Longstaff C; Roberts I; Kolev K; Wohner N
J Thromb Haemost; 2024 Mar; 22(3):794-804. PubMed ID: 38016517
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis of primary hyperfibrinolysis and in vitro investigation of the inhibitory effects of tranexamic acid in a group of dogs with sarcomas - A pilot study.
Langhorn R; Poulsen MK; Heidemann PL; Bochsen L; Ritz C; Kristensen AT; Nielsen LN
Res Vet Sci; 2021 May; 136():472-477. PubMed ID: 33838456
[TBL] [Abstract][Full Text] [Related]
18. Intramuscular administration of tranexamic acid in a large swine model of hemorrhage with hyperfibrinolysis.
Haberkorn CJ; Severance CC; Wetmore NC; West WG; Ng PC; Cendali F; Pitotti C; Schauer SG; Maddry JK; Bebarta VS; Hendry-Hofer TB
J Trauma Acute Care Surg; 2024 May; 96(5):735-741. PubMed ID: 37962201
[TBL] [Abstract][Full Text] [Related]
19. Concentration-effect relationship for tranexamic acid inhibition of tissue plasminogen activator-induced fibrinolysis in vitro using the viscoelastic ClotPro® TPA-test.
Dibiasi C; Ulbing S; Bancher-Todesca D; Ulm M; Gratz J; Quehenberger P; Schaden E
Br J Anaesth; 2024 Feb; 132(2):343-351. PubMed ID: 37925268
[TBL] [Abstract][Full Text] [Related]
20. Coagulative and fibrinolytic activation in cerebrospinal fluid and plasma after subarachnoid hemorrhage.
Ikeda K; Asakura H; Futami K; Yamashita J
Neurosurgery; 1997 Aug; 41(2):344-9; discussion 349-50. PubMed ID: 9257301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
